Related Experiment Video
Updated: Aug 15, 2026
06:47
Effects of Exposure of Formaldehyde to a Rat Model of Atopic Dermatitis Induced by Neonatal Capsaicin Treatment
Published on: September 27, 2017
Successful desensitization of methylphenidate-induced rash
Ronit Confino-Cohen1, Arnon Goldberg
1Allergy and Clinical Immunology Unit, Meir General Hospital, Kfar Saba, Israel.
Journal of Child and Adolescent Psychopharmacology
|September 30, 2005
Summary
Methylphenidate desensitization successfully treated a patient with attention-deficit/hyperactivity disorder (ADHD) who experienced two prior rashes. This protocol allowed for continued, safe ADHD treatment without adverse reactions during a 6-month follow-up.
Area of Science:
- Pharmacology
- Dermatology
- Neuroscience
Background:
- Methylphenidate is a primary treatment for attention-deficit/hyperactivity disorder (ADHD).
- Cutaneous adverse reactions can limit methylphenidate's therapeutic use.
- Developing a method to continue methylphenidate therapy in patients with skin reactions is crucial.
Observation:
- A patient experienced a rash twice after methylphenidate administration.
- A 10-day desensitization protocol was initiated, involving gradually increasing methylphenidate doses every 30 minutes.
- The protocol aimed to reach a therapeutic dose and maintain regular administration.
Findings:
- No adverse reactions were observed during the methylphenidate desensitization period.
- The patient tolerated the therapeutic dose of methylphenidate without skin reactions.
- A 6-month follow-up confirmed the sustained safety and efficacy of the desensitization protocol.
Implications:
- Methylphenidate desensitization is a viable strategy for managing non-life-threatening cutaneous adverse reactions.
- This protocol may allow patients with ADHD to continue essential methylphenidate treatment safely.
- Further research into desensitization protocols for methylphenidate-induced skin reactions is warranted.
Related Concept Videos
01:30Drug Toxicity: Allergic Reactions
Drug-related allergies are immune-mediated responses triggered by the administration of pharmacological agents. These hypersensitivity reactions are classified based on the immune mechanisms involved. The four primary types—Type I, II, III, and IV—are mediated by different immunological pathways and exhibit distinct clinical manifestations.Type I Hypersensitivity/ IgE-Mediated Reactions: Immunoglobulin E (IgE) immediately mediates Type I hypersensitivity reactions. Upon initial exposure to a...
01:20Desensitization and Tachyphylaxis
Tachyphylaxis is described as a rapid decrease in response to a drug after repeated or continuous administration of the same drug dose. It is a phenomenon where the body becomes less responsive to a particular substance or intervention over time, requiring higher doses or stronger interventions to achieve the same effect. It results from adaptive changes in the body's receptors, signaling pathways, or physiological processes that occur in response to prolonged exposure to a stimulus.
Several...
Several...
02:06Allergic Reactions
Overview
01:26Rocky Mountain Spotted Fever
Rocky Mountain Spotted Fever (RMSF) is a severe tick-borne illness caused by Rickettsia rickettsii, a Gram-negative, coccobacillary bacterium. This pathogen is an obligate intracellular parasite, requiring a host cell for replication. Transmission occurs through the bite of an infected tick. In the United States, the most important vectors are Dermacentor variabilis (American dog tick) and Dermacentor andersoni (Rocky Mountain wood tick), though other tick species may also serve as vectors.